Overview
The Life Sciences Symposium, a new initiative from the Oliver Wyman Health Innovation Center, was designed to foster deep discussions among participants from across the healthcare sector.
This intimate gathering focused on the evolving role and future of life sciences, offering a unique opportunity for stakeholders to engage in meaningful conversations and deepen their collaboration. The symposium highlighted the importance of innovation and partnership in addressing the challenges and opportunities within the life sciences field. You can review the full event agenda, here.
Event Recap
Symposium Highlights
Conversation Leaders
Mert Aral, MD
Chief Medical Officer, Huma
Damon Broyles, MD
VP, Clinical Innovation and Medical Director, MCED Precision Medicine; Mercy Health System
Camille DeSantis
Managing Director, US Lead Health Brand Development, Edelman
Sarah Emond
President and CEO, ICER
Phyllis Ferrell
Chief Impact Officer, StartUp Health’s Alzheimer Moonshot
Matthew Gibbs, PharmD
Chief Pharmacy Officer, Blue Shield of California
Emily Hill
CFO, Replimune
Cosmina Hogea, PhD
Senior Director, PatientFocused Implementation Science, Global Medical Strategic Operations, Gilead Sciences
Brigham Hyde, PhD
CEO and Co-founder, Atropos Health
Laura Jensen
Head of Business Development, Amazon Pharmacy
Chris Mancill
SVP and Head, US Market Access, AstraZeneca
Neil Parikh, MD
Chief Medical Officer, Thirty Madison
Daniel Rosan
CFO, Ascidian Therapeutics
Erika Taurel
CFO, Javara
Alexandra von Plato
Chairwoman, Publicis